Cargando…
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors
BACKGROUND: Targeting angiogenesis has been considered a promising treatment of choice for a large number of malignancies, including gastrointestinal cancers. Bevacizumab is an anti-vascular endothelial growth factor (anti-VEGF) being used for this purpose. However, treatment efficacy is largely que...
Autores principales: | Mahfouz, Nadine, Tahtouh, Roula, Alaaeddine, Nada, El Hajj, Joelle, Sarkis, Riad, Hachem, Ray, Raad, Issam, Hilal, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466359/ https://www.ncbi.nlm.nih.gov/pubmed/28594907 http://dx.doi.org/10.1371/journal.pone.0179202 |
Ejemplares similares
-
Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study
por: Tahtouh, Roula, et al.
Publicado: (2015) -
Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532
por: Wardi, Layal, et al.
Publicado: (2014) -
N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022) -
The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression
por: Kirkpatrick, Katharine L, et al.
Publicado: (2004) -
Alterations in p53 Influence hTERT, VEGF and MMPs Expression in Oral Cancer Patients
por: Singh, Ragini D, et al.
Publicado: (2022)